Isatuximab: Nursing Considerations for Use in the Treatment of Multiple Myeloma.

Background: Isatuximab is a CD38 monoclonal antibody approved for use in combination with pomalidomide plus dexamethasone to treat adults with relapsed/refractory multiple myeloma who have received at least two prior therapies. Because isatuximab is a relatively new treatment option, published guidelines for oncology nurses are limited.

Objectives: This article provides nurses with guidance on all aspects of isatuximab administration and patient management to better support those receiving this treatment.